PFE
Pfizer Inc.
Pfizer Inc. insider trading
Pfizer Inc. files with the SEC as a Pharmaceutical Preparations company headquartered in New York, NY. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent PFE insider transactions
4 insiders traded PFE on the open market between Jun 09, 2026 and Aug 12, 2026 — 3 purchases worth $3M, 2 sales worth $134.7K.
- Bought
- $3M
- Sold
- $134.7K
- Net
- +$2.8M
- Insiders
- 4
none on a 10b5-1 plan
Bourla Albert
Chairman & CEO · Director
+$1M
Aug 12, 2026
38,000 sh · $26.34
Damico Jennifer B.
SVP & Controller
−$83.3K
Aug 05, 2026
3,278 sh · $25.40
Blaylock Ronald E
Director
+$998.8K
Aug 05, 2026
39,231 sh · $25.46
Buckley Mortimer J
Director
+$960.4K
Aug 05, 2026
37,632 sh · $25.52
Damico Jennifer B.
SVP & Controller
−$51.4K
Jun 09, 2026
2,000 sh · $25.70
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Bourla AlbertChairman & CEO · Director | 38,000 | $26.34 | +$1M |
| Aug 05, 2026 | Damico Jennifer B.SVP & Controller | 3,278 | $25.40 | −$83.3K |
| Aug 05, 2026 | Blaylock Ronald EDirector | 39,231 | $25.46 | +$998.8K |
| Aug 05, 2026 | Buckley Mortimer JDirector | 37,632 | $25.52 | +$960.4K |
| Jun 09, 2026 | Damico Jennifer B.SVP & Controller | 2,000 | $25.70 | −$51.4K |
SEC Form 4 data, Q3 2024 to Q2 2026
PFE insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 3 insiders traded PFE on the open market: 2 purchases worth $527.3K and 3 sales worth $263.9K. In the last four quarters alone: 0 purchases and 1 sale ($51.4K), by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$51.4K1 sale | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | +$499.1K1 buy | −$64.8K1 sale | |
| Q4 2024 | +$28.2K1 buy | — | |
| Q3 2024 | — | −$147.7K1 sale |
- Largest purchase
- +$499.1K of PFE by Blaylock Ronald E (Director) on Feb 13, 2025.
- Largest sale
- −$147.7K of PFE by Damico Jennifer B. (SVP & Controller) on Aug 13, 2024.
Open-market transactions through Jun 30, 2026most recent first
Damico Jennifer B.
SVP & Controller
−$64.8K
Mar 04, 2025
2,500 sh · $25.93
Blaylock Ronald E
Director
+$499.1K
Feb 13, 2025
19,457 sh · $25.65
Gottlieb Scott
Director
+$28.2K
Oct 30, 2024
1,000 sh · $28.24
Damico Jennifer B.
SVP & Controller
−$147.7K
Aug 13, 2024
5,154 sh · $28.66
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 04, 2025 | Damico Jennifer B.SVP & Controller | 2,500 | $25.93 | −$64.8K |
| Feb 13, 2025 | Blaylock Ronald EDirector | 19,457 | $25.65 | +$499.1K |
| Oct 30, 2024 | Gottlieb ScottDirector | 1,000 | $28.24 | +$28.2K |
| Aug 13, 2024 | Damico Jennifer B.SVP & Controller | 5,154 | $28.66 | −$147.7K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Pfizer Inc. company record
- SEC industry classification
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Listed on
- NYSE
- SEC Central Index Key
- 0000078003
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought PFE
What the stock actually did in the 90 days following each open-market purchase
Don't check PFE — let it ping you
Get told the moment an insider moves on PFE
Pro watches Pfizer Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add PFE to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read PFE insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are PFE insiders buying or selling?
- Between Jun 09, 2026 and Aug 12, 2026, 4 Pfizer Inc. insiders made 3 open-market purchases worth $3M and 2 sales worth $134.7K, a net purchase of $2.8M.
- How much PFE stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 3 Pfizer Inc. insiders made 2 open-market purchases worth $527.3K and 3 sales worth $263.9K. In the four quarters to Jun 30, 2026: no purchases and 1 sale ($51.4K). The largest purchase was Blaylock Ronald E buying $499.1K on Feb 13, 2025. The largest sale was Damico Jennifer B. selling $147.7K on Aug 13, 2024.
- What was the largest recent PFE insider trade?
- Bourla Albert (Chairman & CEO · Director) bought $1M of PFE stock on Aug 12, 2026 at about $26.34 a share.
- When did an insider last buy PFE shares?
- The most recent open-market purchase on file is Bourla Albert (Chairman & CEO · Director) buying $1M on Aug 12, 2026.
- Where does PFE insider trading data come from?
- From the Form 4 filings Pfizer Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.